SCHEMBL24401142

SCHEMBL24401142

CCOC(=O)c1cc2c(nc(CO)n2COCC[Si](C)(C)C)s1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.36
MAPT P10636 8/20 0.36
PKM P14618 1/20 0.36
KDM4E B2RXH2 4/20 0.35
NPC1 O15118 2/20 0.34
MAPK14 Q16539 1/20 0.34
HSD17B10 Q99714 4/20 0.33
HPGD P15428 4/20 0.33
GAA P10253 4/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
TSHR P16473 1/20 0.33
GLA P06280 1/20 0.33
CASP1 P29466 1/20 0.33
CASP7 P55210 1/20 0.33
ATM Q13315 1/20 0.33
NPSR1 Q6W5P4 2/20 0.32
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
ALOX15 P16050 1/20 0.32
TRPM8 Q7Z2W7 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29924211 0.91 MAPT (0.36) ALDH1A1MAPTPKMKDM4ENPC1
SCHEMBL24401144 0.91 MAPT (0.36) ALDH1A1MAPTPKMKDM4ENPC1
SCHEMBL6306238 0.88 MAPT (0.38) ALDH1A1MAPTPKMKDM4ENPC1
SCHEMBL25712948 0.84 KDM4E (0.38) ALDH1A1MAPTPKMKDM4ENPC1
SCHEMBL25712865 0.81 CYP1A2 (0.39) ALDH1A1KDM4ENPC1TSHR
SCHEMBL25120298 0.80 CSNK2A2 (0.36) ALDH1A1MAPTKDM4ENPC1HSD17B10
SCHEMBL25978729 0.77 TSHR (0.41) ALDH1A1MAPTPKMKDM4ENPC1
SCHEMBL25712964 0.75 SUV39H2 (0.34) ALDH1A1MAPTPKMKDM4EGAA
SCHEMBL25119888 0.74 CCNT1 (0.31)
SCHEMBL24400818 0.74 ADORA1 (0.38) ALDH1A1KDM4EHPGDGAASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230234968-A1 METHYL-SUBSTITUTED BENZOBISOXAZOLE COMPOUND AND USE THEREOF TONGHUA DONGBAO PHARMACEUTICAL CO., LTD. (CN) 2023-07-27 US disclosed
US-11542272-B2 Five-membered heteroaryl-fused imidazole compound and application thereof HANGZHOU SCIWIND BIOSCIENCES CO., LTD (CN) 2023-01-03 US disclosed
US-20220135588-A1 Five-Membered Heteroaryl-Fused Imidazole Compound And Application Thereof HANGZHOU SCIWIND BIOSCIENCES CO., LTD (CN) 2022-05-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220135588-A1 Five-Membered Heteroaryl-Fused Imidazole Compound And Application Thereof GLP1R, GIPR, GPR119 ALDH1A1 1731/4885MAPT 4433/4885PKM 3202/4885
US-20230234968-A1 METHYL-SUBSTITUTED BENZOBISOXAZOLE COMPOUND AND USE THEREOF CYP11B2, CYP11B1, TPMT ALDH1A1 1062/4885MAPT 2181/4885PKM 594/4885
US-11542272-B2 Five-membered heteroaryl-fused imidazole compound and application thereof GLP1R, GIPR, GPR119 ALDH1A1 1731/4885MAPT 4433/4885PKM 3202/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.